TGFBR1与TGFBR2基因变异在马凡综合征中的作用
研究纳入75例无亲缘关系的马凡综合征患者,行FBN1及TGFBR1/2的Sanger测序,未发现TGFBR1/2致病突变,但鉴定出多个常见多态性;携带保护性等位基因或遗传评分≥2个保护等位基因者主动脉z评分更低,重度主动脉表现比例更低。
要点
- 马凡综合征患者中TGFBR1/2未检出致病突变,不支持其作为主要致病基因。
- TGFBR1/2多个常见多态性与主动脉z评分降低相关。
- 携带≥2个保护等位基因者重度主动脉表现比例更低且风险降低。
核心结论
- TGFBR1/2并非马凡综合征的主要致病基因,但其遗传变异以负荷评分形式可能调节心血管表现严重程度。
研究设计与样本
- 研究纳入75例无亲缘关系的马凡综合征患者,来自佛罗伦萨Careggi大学医院马凡综合征及相关疾病中心,行FBN1及TGFBR1/2的Sanger测序。
主要发现
- rs11466512的A等位基因、c.383delA的delA等位基因、c.1256-15del1T的delT等位基因携带者主动脉z评分中位数分别为2.2(IQR 1.13-4.77)、2.1(IQR 1.72-3.48)、2.5(IQR 1.85-3.86),野生型纯合患者分别为4.20(IQR 2.39-7.25)、3.9(IQR 2.19-7.00)、3.9(IQR 2.14-6.93)。
- rs2276767的A等位基因携带者主动脉z评分中位数为4.9(IQR 2.14-7.16),野生型患者为3.3(IQR 1.75-5.45)。
临床怎么用
- 马凡综合征遗传诊断仍应以FBN1为主,TGFBR1/2不推荐作为常规致病基因筛查。
- TGFBR1/2多态性评分可能辅助评估主动脉病变严重程度,但需进一步验证。
局限性
- 样本量较小(75例),多态性关联分析需更大样本验证。
- 研究为单中心横断面设计,未评估纵向主动脉事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Genetic variants in transforming growth factor beta (TGF-β) receptors type 1 (TGFBR1) and type 2 (TGFBR2) genes have been associated with different hereditary connective tissue disorders sharing thoracic aortic aneurysm and dissection (TAA/D). Mutations in both TGFBR1/2 genes have been described in patients with TAA/D and Marfan syndrome (MFS), and they are associated consistently with Loeys-Dietz syndrome. The existing literature shows discordant data resulting from mutational screening of TGFBR1/2 genes in patients with MFS. The aim of the study was to investigate the role of TGFBR1/2 genetic variants in determining and/or modulating MFS clinical phenotype. METHODS: We investigated 75 unrelated patients with MFS referred to the Center for Marfan Syndrome and Related Disorders (Careggi University Hospital, Florence) who were subjected to FBN1 and TGFBR1/2 Sanger mutational screening. RESULTS: Forty-seven patients with MFS (63%) carried a pathogenetic FBN1 mutation. No pathogenetic mutations were detected in TGFBR1/2 genes. Ten common polymorphisms were identified in TGFBR2 and 6 in TGFBR1. Their association with cardiovascular manifestations was evaluated. Carriers of the A allele of rs11466512, delA allele of c.383delA or delT allele of c.1256-15del1T polymorphisms had a trend toward or significantly reduced z-scores (median [interquartile range (IQR)], 2.2 [1.13-4.77]; 2.1 [1.72-3.48]; 2.5 [1.85-3.86]) with respect to homozygous patients with wild-type MFS (median [IQR], 4.20 [2.39-7.25]; 3.9 [2.19-7.00]; 3.9 [2.14-6.93]). Carriers of the A allele of the rs2276767 polymorphism showed a trend toward increased z-score (median [IQR], 4.9 [2.14-7.16]) with respect to patients with wild-type MFS (median [IQR], 3.3 [1.75-5.45]). The protective effect of TGFBR1/2 genetic score including all the 4 variants was also evaluated. Patients with MFS with two or more protective alleles included in the score had statistically significant reduced aortic z-scores (median [IQR], 2.20 [1.48-3.37]) with respect to patients with 1 or no protective alleles (median [IQR], 4.20 [2.48-7.12]; P = .007). Patients with severe aortic manifestations (aortic z-score ≥ 2 or aortic surgery) showed a significantly lower prevalence of subjects with two or more protective alleles included in the genetic score (29.7%) than patients with no or milder cardiovascular involvement (63.6%; P = .029). The genetic score protective effect on global aortic manifestations severity (aortic z-score ≥ 2 or aortic surgery) was also observed at the logistic regression analysis adjusted for the presence of FBN1 gene mutations (odds ratio, 0.21; 95% CI, 0.05-0.84; P = .028). CONCLUSIONS: In conclusion, our data reappraise the role of TGFBR1 and TGFBR2 as major genes in patients with MFS, and suggest that TGFBR1/2 genetic variants (in particular when evaluated as a burden by score) might play a role in modulating the severity of cardiovascular manifestation in MFS.
引用
- De Cario R, Sticchi E, Lucarini L, et al. Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome. J Vasc Surg. 2017. PMID: 28847661. doi:10.1016/j.jvs.2017.04.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。